Education, Health, Lifestyle, Technology

Top 5 Innovative Health Tech Devices for 2021

Top 5 Innovative Health Tech Devices for 2021

Nuances in modern language are beginning to paint a portrait of posthumanist philosophies, being delivered incrementally into reality, through advances in science and the medical industry. In an era when academics debate biological terms, some are beginning to wonder what it will even mean to be ‘human’ decades from now.

In a future with cybernetic implants and artificial embryos, will the terms and spectrums we use today even matter? It’s anyone’s guess, but innovations in medical tech do provoke such questions. In this article, we’re going to examine some of the most innovative tech inventions for health, and the frameworks science and medtech communities are placing for the future.

Robotic exoskeletons

One major problem of developing bipedal, humanoid prosthetics and robotics is the fact it’s a miracle humans can even stand upright. The biomechanics of human limb movement, particularly how humans walk, have eluded the robotics community for many years. Upright walking is in fact a delicate balancing act, requiring almost conscious adjustments made mid-step. How many humans stumble everyday while walking?

Well, even though bipedal, humanoid robots are quite a ways off, significant ground has been made in the areas of prosthetic limbs, and biomechanical exoskeletons. Tech startups like ABLE have developed robotic lower-body exoskeletons, which can allow people with disabilities such as lower-limb paralysis, to experience walking again.

These exoskeletons also include smart device capabilities, for remote monitoring and adjustments made in parameters for each individual patient. This is important, as the human gait can widely vary by individual, taking into account things like posture and body weight distribution.

Pexels photo

Bionic eyes

Like much of our body, our eyes have long eluded scientific attempts at artificial emulation. The spherical shape of the retina, and how we perceive light and colour spectrums, have always posed a particular challenge to bionic eye implants.

Researchers however have been putting together the puzzle pieces at a time, and have recently made major breakthroughs. By implanting nanowires attached to artificial retinas, researchers conclude that bionic eye implants in human patients could very well be a reality in the next decade.

Other medtech companies have made advances in addressing eye-related issues, such as the link between light absorption and acute migraines. Migraine glasses from Axon Optics, for example, use special tinting designed to block out harsh fluorescent lighting, without darkening your vision as normal sunglasses would.

C02 removal devices

Traditional respirators cannot remove the buildup of carbon dioxide in a patient’s blood, as witnessed in chronic pulmonary diseases. New medtech devices in providing extracorporeal carbon dioxide removal have shown promise in saving lives afflicted by a variety of lung and heart diseases, most notably acute asthma and life-threatening asthma attacks.

Medtech startups utilized AI machine learning to create a hybrid treatment approach, where a patient’s blood can be drawn through tiny catheters placed by nursing staff. These procedures are less invasive than existing techniques to treat acute lung failure, and the technology can be utilized outside of intensive care units for treating patients with a variety of diseases, such as COPD and cystic fibrosis.


Tiny, cell-like robots floating around in your bloodstream, attacking diseased cells and impurities? It’s not a science fiction movie, it’s the very real advances in nanomedicine technology the past several years. While a lot of funding has been poured into the design and laboratory experimentation of nanobots, the medtech industry is finally ready to start putting the research into public clinical trials with humans.

Companies like CytImmune Sciences, which lead the research in cancer nanomedicines, have completed Phase I trials in using nanoparticles for delivering treatment payloads to tumors. Biopharmaceutical companies like BlueWillow Biologics have also developed nanotech aimed at fighting viruses and bacteria.

With nanotechnology, one of the hurdles the medtech industry faces is public opinion and questions of ethics. There exists a significant portion of the population that will need convincing to accept tiny robots out of science fiction movies into their bodies, in an era where 5G radio signals are somehow blamed for spreading COVID-19.

Mechanical wombs

“The holy grail of developmental biology is to understand how a single cell, a fertilized egg, can make all of the specific cell types in the human body and grow into 40 trillion cells. Since the beginning of time, researchers have been trying to develop ways to answer this question.” – Dr. Tesar, Case Western Reserve University School of Medicine.

In layman’s terms, they’ve successfully grown mice embryos in artificial wombs, with fertilized eggs taken from the oviducts of female mice immediately after fertilization. There still exists a mammalian womb to the artificial womb pipeline, but they’ve narrowed it down to mere moments after fertilization.

Along with studies like genome research, does this forebode a future like in The Matrix, where human fetuses are grown like cornfields? Probably not. Most certainly not in our lifetime. But it does show promise for understanding mammalian birth, and creating new opportunities for women unable to bear children due to medical reasons.

Biology, physiology, and postmodern philosophy are incredibly hot topics in the mainstream today, and much of the discourse relies on ideological narratives.

No matter the various conflicting ideologies behind the public discourse, however, it is certain that the advances in medtech today are narrowing the gap between science fiction and reality closer than ever before.

Leave a Reply

Your email address will not be published. Required fields are marked *

Applications for this programme are now closed

Thank you for your interest!

International‌ ‌Applicants‌ ‌-‌ ‌please‌ ‌note:‌

Housemanship‌ ‌and‌ ‌Registration‌ ‌(International‌ ‌Graduates)‌

International‌ ‌Graduates‌ ‌may‌ ‌not‌ ‌be‌ ‌able‌ ‌to‌ ‌obtain‌ ‌a‌ ‌pre-registration‌ ‌internship‌ ‌in‌ ‌Malaysia‌ ‌and‌ ‌you‌ ‌ should‌ ‌therefore‌ ‌ensure‌ ‌that‌ ‌your‌ ‌own‌ ‌country‌ ‌will‌ ‌offer‌ ‌you‌ ‌a‌ ‌house‌ ‌officer‌ ‌post‌ ‌after‌ ‌qualifying‌ ‌at‌ ‌ NUMed.‌

There‌ ‌is‌ ‌currently‌ ‌specific‌ ‌recognition‌ ‌of‌ ‌NUMed‌ ‌by‌ ‌the‌ ‌Medical‌ ‌Councils‌ ‌of‌ ‌India,‌ ‌Sri‌ ‌Lanka‌ ‌ and‌ ‌Thailand.‌ ‌Applicants‌ ‌from‌ ‌those‌ ‌countries‌ ‌are‌ ‌advised‌ ‌to‌ ‌register‌ ‌with‌ ‌the‌ ‌appropriate‌ ‌ medical‌ ‌council‌ ‌before‌ ‌entering‌ ‌NUMed.‌

Newcastle‌ ‌University‌ ‌Medicine‌ ‌Malaysia‌ ‌is‌ ‌listed‌ ‌in‌ ‌the‌ ‌World‌ ‌Directory‌ ‌of‌ ‌Medical‌ ‌Schools‌ ‌ (WDOMS‌,‌ ‌‌‌)‌ ‌maintained‌ ‌by‌ ‌‌World‌ ‌Federation‌ ‌for‌ ‌Medical‌ ‌Education‌ ‌(WFME)‌ ‌and‌ ‌ the‌ ‌Foundation‌ ‌for‌ ‌Advancement‌ ‌of‌ ‌International‌ ‌Medical‌ ‌Education‌ ‌and‌ ‌Research‌ ‌(FAIMER).‌ ‌Our‌ ‌ FAIMER‌ ‌School‌ ‌ID‌ ‌is:‌ ‌F0003188.

EU/UK Citizen

Applicants holding passport from European Union country and United Kingdom, please contact to check your eligibility to apply for any of our programmes.

Privacy Policy

By entering your email address, you agree to receive our email communications from the University in accordance with our Privacy Policy.

Assuming you do not take up an offer to study at the University, and in meeting the University’s Public Task and Legal Obligations, the University will retain some anonymised data relating to your application in perpetuity whilst retaining other personal data relating to your application to the University for up to five years to meet sector best practice. If you do take up an offer to study at the University, retention periods for your personal data are as detailed in the Student Privacy Notice.

Terms & service

The University accepts a broad range of qualifications and combinations of qualifications for entry to its programmes of study, and a wide range of qualifications offered by international applicants.

All applications received are to be given equal consideration. This means that in some subjects, because of limits to the number of places available, some or all applications may be held until the document received are complete.

Offers of places to applicants are to be made, within the constraints of the number of places available, based on individual academic achievement, ability and potential to succeed on their chosen programme of study. This is regardless of age, religion or belief, race, ethnicity, gender, being trans gender, marital or family status, sexual orientation, or disability. Exceptionally, it may not be possible to make offers to applicants with a disability in cases where the adjustments that would be needed to make a programme of study accessible to an applicant are demonstrably unreasonable within the terms of the Equality Act 2010.

Applicants are expected to disclose information about any disability, including mental health, that would help the University to identify and provide help with support needs.

Admissions decisions are to be based, within the constraints of the number of places available, on professional judgement of applicants’ individual academic achievement, ability and potential, considering all the information presented in applications and applying established entry criteria in a consistent manner.

It follows, therefore, that it is the responsibility of applicants and referees to provide full and accurate information in an application and to notify the University of any changes or corrections to the original application.

Some degree programmes have criteria for assessment of applicants other than entry grade requirements. Admissions tests, portfolios or interviews are examples. Such requirements will be set out in the entrance requirements for individual degree programmes.